These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 32975318)

  • 41. Promise and challenges of dystonia brain banking: establishing a human tissue repository for studies of X-Linked Dystonia-Parkinsonism.
    Fernandez-Cerado C; Legarda GP; Velasco-Andrada MS; Aguil A; Ganza-Bautista NG; Lagarde JBB; Soria J; Jamora RDG; Acuña PJ; Vanderburg C; Sapp E; DiFiglia M; Murcar MG; Campion L; Ozelius LJ; Alessi AK; Singh-Bains MK; Waldvogel HJ; Faull RLM; Macalintal-Canlas R; Muñoz EL; Penney EB; Ang MA; Diesta CCE; Bragg DC; Acuña-Sunshine G
    J Neural Transm (Vienna); 2021 Apr; 128(4):575-587. PubMed ID: 33439365
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Identification and localization of a neuron-specific isoform of TAF1 in rat brain: implications for neuropathology of DYT3 dystonia.
    Sako W; Morigaki R; Kaji R; Tooyama I; Okita S; Kitazato K; Nagahiro S; Graybiel AM; Goto S
    Neuroscience; 2011 Aug; 189():100-7. PubMed ID: 21616129
    [TBL] [Abstract][Full Text] [Related]  

  • 43. TAF1 Variants Are Associated with Dysmorphic Features, Intellectual Disability, and Neurological Manifestations.
    O'Rawe JA; Wu Y; Dörfel MJ; Rope AF; Au PY; Parboosingh JS; Moon S; Kousi M; Kosma K; Smith CS; Tzetis M; Schuette JL; Hufnagel RB; Prada CE; Martinez F; Orellana C; Crain J; Caro-Llopis A; Oltra S; Monfort S; Jiménez-Barrón LT; Swensen J; Ellingwood S; Smith R; Fang H; Ospina S; Stegmann S; Den Hollander N; Mittelman D; Highnam G; Robison R; Yang E; Faivre L; Roubertie A; Rivière JB; Monaghan KG; Wang K; Davis EE; Katsanis N; Kalscheuer VM; Wang EH; Metcalfe K; Kleefstra T; Innes AM; Kitsiou-Tzeli S; Rosello M; Keegan CE; Lyon GJ
    Am J Hum Genet; 2015 Dec; 97(6):922-32. PubMed ID: 26637982
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Understanding XDP through imaging, pathology, and genetics.
    Pasco PM; Ison CV; Muňoz EL; Magpusao NS; Cheng AE; Tan KT; Lo RW; Teleg RA; Dantes MB; Borres R; Maranon E; Demaisip C; Reyes MV; Lee LV
    Int J Neurosci; 2011; 121 Suppl 1():12-7. PubMed ID: 21034368
    [TBL] [Abstract][Full Text] [Related]  

  • 45. TAF1-gene editing alters the morphology and function of the cerebellum and cerebral cortex.
    Janakiraman U; Yu J; Moutal A; Chinnasamy D; Boinon L; Batchelor SN; Anandhan A; Khanna R; Nelson MA
    Neurobiol Dis; 2019 Dec; 132():104539. PubMed ID: 31344492
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The roles of TAF1 in neuroscience and beyond.
    Crombie EM; Cleverley K; Timmers HTM; Fisher EMC
    R Soc Open Sci; 2024 Sep; 11(9):240790. PubMed ID: 39323550
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Blood neurofilament light chain as a surrogate marker for dystonia.
    Wu MC; Chang YY; Lan MY; Chen YF; Tai CH; Chen SJ; Lin CH
    Eur J Neurol; 2023 Oct; 30(10):3098-3104. PubMed ID: 37422850
    [TBL] [Abstract][Full Text] [Related]  

  • 48. DNA binding properties of TAF1 isoforms with two AT-hooks.
    Metcalf CE; Wassarman DA
    J Biol Chem; 2006 Oct; 281(40):30015-23. PubMed ID: 16893881
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Congenital Heart Defects Due to
    Morton SU; Agarwal R; Madden JA; Genetti CA; Brownstein CA; López-Giráldez F; Choi J; Seidman CE; Seidman JG; Lyon GJ; Agrawal PB
    Circ Genom Precis Med; 2020 Jun; 13(3):e002843. PubMed ID: 32396742
    [No Abstract]   [Full Text] [Related]  

  • 50. Control of alternative splicing by signal-dependent degradation of splicing-regulatory proteins.
    Katzenberger RJ; Marengo MS; Wassarman DA
    J Biol Chem; 2009 Apr; 284(16):10737-46. PubMed ID: 19218244
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Clinicopathological Phenotype and Genetics of X-Linked Dystonia-Parkinsonism (XDP; DYT3; Lubag).
    Kawarai T; Morigaki R; Kaji R; Goto S
    Brain Sci; 2017 Jun; 7(7):. PubMed ID: 28672841
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Validation of Serum Neurofilament Light Chain as a Biomarker of Parkinson's Disease Progression.
    Mollenhauer B; Dakna M; Kruse N; Galasko D; Foroud T; Zetterberg H; Schade S; Gera RG; Wang W; Gao F; Frasier M; Chahine LM; Coffey CS; Singleton AB; Simuni T; Weintraub D; Seibyl J; Toga AW; Tanner CM; Kieburtz K; Marek K; Siderowf A; Cedarbaum JM; Hutten SJ; Trenkwalder C; Graham D
    Mov Disord; 2020 Nov; 35(11):1999-2008. PubMed ID: 32798333
    [TBL] [Abstract][Full Text] [Related]  

  • 53. X-Linked Parkinsonism: Phenotypic and Genetic Heterogeneity.
    Di Lazzaro G; Magrinelli F; Estevez-Fraga C; Valente EM; Pisani A; Bhatia KP
    Mov Disord; 2021 Jul; 36(7):1511-1525. PubMed ID: 33960519
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Complicated recessive dystonia parkinsonism syndromes.
    Schneider SA; Bhatia KP; Hardy J
    Mov Disord; 2009 Mar; 24(4):490-9. PubMed ID: 19185014
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A scoping review on the diagnosis and treatment of X-linked dystonia-parkinsonism.
    Alonto AHD; Jamora RDG
    Parkinsonism Relat Disord; 2024 Feb; 119():105949. PubMed ID: 38072720
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Frameshift Mutations in the Mononucleotide Repeats of TAF1 and TAF1L Genes in Gastric and Colorectal Cancers with Regional Heterogeneity.
    Oh HR; An CH; Yoo NJ; Lee SH
    Pathol Oncol Res; 2017 Jan; 23(1):125-130. PubMed ID: 27571988
    [TBL] [Abstract][Full Text] [Related]  

  • 57. TAF1 differentially enhances androgen receptor transcriptional activity via its N-terminal kinase and ubiquitin-activating and -conjugating domains.
    Tavassoli P; Wafa LA; Cheng H; Zoubeidi A; Fazli L; Gleave M; Snoek R; Rennie PS
    Mol Endocrinol; 2010 Apr; 24(4):696-708. PubMed ID: 20181722
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Neuroenergetic Changes in Patients with X-Linked Dystonia-Parkinsonism and Female Carriers.
    Prasuhn J; Henkel J; Algodon SM; Uter J; Rosales RL; Klein C; Steinhardt J; Diesta CC; Brüggemann N
    Mov Disord Clin Pract; 2024 May; 11(5):550-555. PubMed ID: 38404049
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prodromal X-Linked Dystonia-Parkinsonism is Characterized by a Subclinical Motor Phenotype.
    Steinhardt J; Hanssen H; Heldmann M; Sprenger A; Laabs BH; Domingo A; Reyes CJ; Prasuhn J; Brand M; Rosales R; Münte TF; Klein C; Westenberger A; Oropilla JQ; Diesta C; Brüggemann N
    Mov Disord; 2022 Jul; 37(7):1474-1482. PubMed ID: 35491955
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Evaluation of the effects of the T-type calcium channel enhancer SAK3 in a rat model of TAF1 deficiency.
    Dhanalakshmi C; Janakiraman U; Moutal A; Fukunaga K; Khanna R; Nelson MA
    Neurobiol Dis; 2021 Feb; 149():105224. PubMed ID: 33359140
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.